Study: CBD Effective As Adjunctive Therapy For Psychosis

Generic 20 December 2017 | 0 Comments

The daily administration of CBD (cannabidiol) as an adjunctive therapy mitigates psychotic symptoms in patients with schizophrenia, according to clinical trial data published online ahead of print in The American Journal of Psychiatry. British researchers assessed the adjunctive use of CBD compared to placebo over a six-week period in a randomized trial of 88 schizophrenic [...]

Tagged in ,

WHO Finalizes CBD Recommendations

Generic 14 December 2017 | 0 Comments

The use of the naturally occurring cannabinoid CBD (cannabidiol) possesses no likely abuse potential and therefore should not be subject to international drug scheduling restrictions, according to recommendations finalized today by the World Health Organization’s Expert Committee on Drug Dependence. Concludes WHO: “Recent evidence from animal and human studies shows that its use could have [...]

Tagged in , , ,

WHO Report: No Public Health Problems Attributable To CBD

Generic 12 December 2017 | 0 Comments

The use of the naturally occurring cannabinoid CBD is safe, well tolerated, and is not associated with any significant adverse public health effects, according to the findings of a preliminary report compiled by the World Health Organization’s Expert Committee on Drug Dependence. Authors of the report declare that CBD is “not associated with abuse potential” [...]

Tagged in , , ,

CBD may protect against psychiatric risk from high-THC cannabis strains

Did you know that? 12 September 2017 | 0 Comments

A study by neuroscientists finds that a non-psychoactive compound in cannabis called cannabidiol, or CBD, appears to protect against the long-term negative psychiatric effects of THC, the primary psychoactive ingredient in cannabis.

Tagged in ,

FDA Seeking Public Comments On CBD

Generic 30 August 2017 | 0 Comments

On Regulations.Gov, right now, the Federal Food and Drug Administration (FDA) is soliciting public comments with regard to the therapeutic utility and abuse liability of various controlled substances, including cannabidiol (CBD). The agency will consider these comments prior to preparing a formal response to the World Health Organization, which is considering placing the substances within their [...]

Tagged in , ,